MIKAELA LAVALLEE: Open Payments
NPI 1770970790 · SHREWSBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 48 payments from 12 companies in 2025. Trend: 2023 $312 · 2024 $713 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $156 |
| Exact Sciences Corporation | 7 | $154 |
| Janssen Pharmaceuticals, Inc | 9 | $150 |
| PFIZER INC. | 5 | $96 |
| Lundbeck LLC | 4 | $94 |
| Aimmune Therapeutics, Inc. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Ardelyx, Inc. | 2 | $50 |
| Abbott Laboratories | 1 | $21 |
Products named: REXULTI, Cologuard Collection Kit, SPRAVATO, NURTEC ODT, JARDIANCE, VOWST, XIFAXAN, IBSRELA.
Industry payments across MA — which companies pay providers there.
